Progyny (NASDAQ:PGNY) Releases Q4 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its fourth quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.07-0.10 for the period, compared to the consensus EPS estimate of $0.14. The company issued revenue guidance of $266.2-281.2 million, compared to the consensus revenue estimate of $292.69 million.

Progyny Price Performance

Shares of NASDAQ PGNY traded up $0.12 during mid-day trading on Tuesday, hitting $17.18. 1,973,334 shares of the stock traded hands, compared to its average volume of 1,371,481. The firm has a 50 day simple moving average of $18.01 and a two-hundred day simple moving average of $23.73. Progyny has a twelve month low of $13.93 and a twelve month high of $42.08. The company has a market cap of $1.55 billion, a PE ratio of 27.08, a price-to-earnings-growth ratio of 1.57 and a beta of 1.44.

Analyst Upgrades and Downgrades

Several analysts have commented on PGNY shares. Jefferies Financial Group lowered their price objective on shares of Progyny from $31.00 to $24.00 and set a “buy” rating for the company in a report on Thursday, September 19th. Canaccord Genuity Group lowered their price target on shares of Progyny from $24.00 to $18.00 and set a “hold” rating for the company in a research report on Friday, September 20th. Truist Financial cut their price objective on shares of Progyny from $33.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, September 19th. Leerink Partners reduced their price target on shares of Progyny from $25.00 to $21.00 and set a “market perform” rating on the stock in a research note on Thursday, September 19th. Finally, JMP Securities downgraded shares of Progyny from an “outperform” rating to a “market perform” rating in a research report on Thursday, September 19th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $27.73.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.